Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

A possible role for CD8+ T lymphocytes in the cell-mediated pathogenesis of pemphigus vulgaris.

Giurdanella F, Fania L, Gnarra M, Toto P, Di Rollo D, Sauder DN, Feliciani C.

Mediators Inflamm. 2013;2013:764290. doi: 10.1155/2013/764290. Epub 2013 Nov 18.

2.

Novel use of polymethyl methacrylate (PMMA) microspheres in the treatment of infraorbital rhytids.

Mani N, McLeod J, Sauder MB, Sauder DN, Bothwell MR.

J Cosmet Dermatol. 2013 Dec;12(4):275-80. doi: 10.1111/jocd.12065.

PMID:
24305426
3.

A recombinant human hyaluronidase sustained release gel for the treatment of post-surgical edema.

Nekoroski T, Paladini RD, Sauder DN, Frost GI, Keller GA.

Int J Dermatol. 2014 Jun;53(6):777-85. doi: 10.1111/ijd.12304. Epub 2013 Oct 29.

PMID:
24168080
4.

Squamous cell carcinoma manifesting as cutaneous cystic lesions.

Shah A, Peloro TM, Sauder DN.

Cutis. 2012 Jan;89(1):45-7.

PMID:
22439312
5.

Light-emitting diodes: their role in skin rejuvenation.

Sauder DN.

Int J Dermatol. 2010 Jan;49(1):12-6. doi: 10.1111/j.1365-4632.2009.04246.x. Review. No abstract available.

PMID:
20465603
6.

IL-12 and IL-23 in health and disease.

Stetsko D, Sauder DN.

Expert Rev Clin Immunol. 2008 May;4(3):301-3. doi: 10.1586/1744666X.4.3.301. No abstract available.

PMID:
20476918
7.

Topical immunotherapy for skin disease.

Wrone DA, Sauder DN.

Expert Rev Clin Immunol. 2007 Jul;3(4):451-4. doi: 10.1586/1744666X.3.4.451. No abstract available.

PMID:
20477149
8.

Nested, non-parametric, correlative analysis of microarrays for heterogenous phenotype characterization.

Kowalski J, Blackford A, Feng C, Mamelak AJ, Sauder DN.

Stat Med. 2007 Feb 28;26(5):1090-101.

PMID:
16817149
9.

Photoaging: mechanisms and repair.

Rabe JH, Mamelak AJ, McElgunn PJ, Morison WL, Sauder DN.

J Am Acad Dermatol. 2006 Jul;55(1):1-19. Review.

PMID:
16781287
10.

Pemphigus vulgaris induced by electrical injury.

Tan SR, McDermott MR, Castillo CJ, Sauder DN.

Cutis. 2006 Mar;77(3):161-5. Review.

PMID:
16610735
11.

Understanding the new clinical landscape for psoriasis: a comparative review of biologics.

Sauder DN, Mamelak AJ.

J Cutan Med Surg. 2004 Jul-Aug;8(4):205-12. Review.

PMID:
16091996
12.

The emerging role of immunotherapy in the treatment of non-melanoma skin cancers.

Sauder DN.

Nat Clin Pract Oncol. 2005 Jul;2(7):326-7. No abstract available.

PMID:
16075786
13.

Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior.

Howell BG, Solish N, Lu C, Watanabe H, Mamelak AJ, Freed I, Wang B, Sauder DN.

J Dermatol Sci. 2005 Jul;39(1):39-51. Epub 2005 Apr 18.

PMID:
15978418
14.

Downregulation of NDUFA1 and other oxidative phosphorylation-related genes is a consistent feature of basal cell carcinoma.

Mamelak AJ, Kowalski J, Murphy K, Yadava N, Zahurak M, Kouba DJ, Howell BG, Tzu J, Cummins DL, LiƩgeois NJ, Berg K, Sauder DN.

Exp Dermatol. 2005 May;14(5):336-48.

PMID:
15854127
15.

Topical immunotherapy: what's new.

Sauder DN, Mofid MZ.

Dermatol Clin. 2005 Apr;23(2):245-58. Review.

PMID:
15837154
16.

Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus model.

Watanabe H, Mamelak AJ, Weiss E, Wang B, Freed I, Brice AK, Wachtman L, Gabrielson KL, Yokota N, Hicklin DJ, Kerbel RS, Haas M, Sauder DN.

Clin Cancer Res. 2005 Jan 1;11(1):407-9. No abstract available.

17.
18.

Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity.

Watanabe H, Mamelak AJ, Wang B, Howell BG, Freed I, Esche C, Nakayama M, Nagasaki G, Hicklin DJ, Kerbel RS, Sauder DN.

Exp Dermatol. 2004 Nov;13(11):671-81.

PMID:
15500639
19.

Interaction of Staphylococcus aureus fibronectin-binding protein with fibronectin: affinity, stoichiometry, and modular requirements.

Ingham KC, Brew S, Vaz D, Sauder DN, McGavin MJ.

J Biol Chem. 2004 Oct 8;279(41):42945-53. Epub 2004 Aug 4.

20.

Clinicopathologic features of ulcerative-atrophic sarcoidosis.

Yoo SS, Mimouni D, Nikolskaia OV, Kouba DJ, Sauder DN, Nousari CH.

Int J Dermatol. 2004 Feb;43(2):108-12.

PMID:
15125500
21.

Microarray analysis of UVB-regulated genes in keratinocytes: downregulation of angiogenesis inhibitor thrombospondin-1.

Howell BG, Wang B, Freed I, Mamelak AJ, Watanabe H, Sauder DN.

J Dermatol Sci. 2004 May;34(3):185-94.

PMID:
15113588
22.

The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases.

Weiss E, Mamelak AJ, La Morgia S, Wang B, Feliciani C, Tulli A, Sauder DN.

J Am Acad Dermatol. 2004 May;50(5):657-75; quiz 676-8. Review.

PMID:
15097948
23.

Randomized, single-blind, placebo-controlled study of topical application of the immune response modulator resiquimod in healthy adults.

Sauder DN, Smith MH, Senta-McMillian T, Soria I, Meng TC.

Antimicrob Agents Chemother. 2003 Dec;47(12):3846-52.

24.

Imiquimod: modes of action.

Bilu D, Sauder DN.

Br J Dermatol. 2003 Nov;149 Suppl 66:5-8. Review. No abstract available. Erratum in: Br J Dermatol. 2006 Jun;154(6):1220. Bilu, Donna [added].

PMID:
14616337
25.

Immunotherapy of basal cell carcinoma: evolving approaches.

Gaspari AA, Sauder DN.

Dermatol Surg. 2003 Oct;29(10):1027-34. Review.

PMID:
12974699
26.

Cytokine knockouts in contact hypersensitivity research.

Wang B, Esche C, Mamelak A, Freed I, Watanabe H, Sauder DN.

Cytokine Growth Factor Rev. 2003 Oct;14(5):381-9. Review.

PMID:
12948522
27.

Urokinase plasminogen activator mRNA is induced by IL-1alpha and TNF-alpha in in vitro acantholysis.

Feliciani C, Toto P, Wang B, Sauder DN, Amerio P, Tulli A.

Exp Dermatol. 2003 Aug;12(4):466-71.

PMID:
12930304
28.

Modulation of the contact hypersensitivity response by AE-941 (Neovastat), a novel antiangiogenic agent.

Dupont E, Wang B, Mamelak AJ, Howell BG, Shivji G, Zhuang L, Dimitriadou V, Falardeau P, Sauder DN.

J Cutan Med Surg. 2003 May-Jun;7(3):208-16.

PMID:
12574904
29.
30.

Low-dose ultraviolet B rays alter the mRNA expression of the circadian clock genes in cultured human keratinocytes.

Kawara S, Mydlarski R, Mamelak AJ, Freed I, Wang B, Watanabe H, Shivji G, Tavadia SK, Suzuki H, Bjarnason GA, Jordan RC, Sauder DN.

J Invest Dermatol. 2002 Dec;119(6):1220-3.

31.

Neovastat (AE-941), an inhibitor of angiogenesis: Randomized phase I/II clinical trial results in patients with plaque psoriasis.

Sauder DN, Dekoven J, Champagne P, Croteau D, Dupont E.

J Am Acad Dermatol. 2002 Oct;47(4):535-41.

PMID:
12271297
32.

Contact hypersensitivity: the mechanism of immune responses and T cell balance.

Watanabe H, Unger M, Tuvel B, Wang B, Sauder DN.

J Interferon Cytokine Res. 2002 Apr;22(4):407-12. Review.

PMID:
12034022
33.
34.

Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity.

Wang B, Feliciani C, Howell BG, Freed I, Cai Q, Watanabe H, Sauder DN.

J Immunol. 2002 Apr 1;168(7):3303-8.

35.

Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts.

Suzuki H, Kalair W, Shivji GM, Wang B, Toto P, Amerio P, Kraemer KH, Sauder DN.

J Invest Dermatol. 2001 Nov;117(5):1151-5.

36.

Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis.

Amerio P, Verdolini R, Proietto G, Feliciani C, Toto P, Shivji G, Loconsole F, Cassano N, Amerio P, Vena G, Sauder DN.

Acta Derm Venereol. 2001 May;81(2):92-5.

37.

Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies.

Wang B, Feliciani C, Freed I, Cai Q, Sauder DN.

J Leukoc Biol. 2001 Aug;70(2):185-91. Review.

PMID:
11493609
38.
39.

cis-Urocanic acid does not induce the expression of immunosuppressive cytokines in murine keratinocytes.

Zak-Prelich M, Norval M, Venner TJ, Bisset Y, Walker C, Rafferty TS, Sauder DN, McKenzie RC.

Photochem Photobiol. 2001 Mar;73(3):238-44.

PMID:
11281019
40.

FcRgamma represents the Fc receptor gamma chain whereas FcgammaR means the Fc receptor for IgG.

Wang B, Sauder DN.

J Invest Dermatol. 2001 Feb;116(2):350. No abstract available.

41.

CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity.

Wang B, Fujisawa H, Zhuang L, Freed I, Howell BG, Shahid S, Shivji GM, Mak TW, Sauder DN.

J Immunol. 2000 Dec 15;165(12):6783-90.

42.

The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris.

Turner MS, Sutton D, Sauder DN.

J Am Acad Dermatol. 2000 Dec;43(6):1058-64.

PMID:
11100023
43.

The effect of VAS972 on allergic contact hypersensitivity.

Shivji GM, Suzuki H, Mandel AS, Bolton AE, Sauder DN.

J Cutan Med Surg. 2000 Jul;4(3):132-7.

PMID:
11003717
44.

Immunomodulatory and pharmacologic properties of imiquimod.

Sauder DN.

J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S6-11. Review.

PMID:
10861101
45.

Molecular mechanism of ultraviolet-induced keratinocyte apoptosis.

Zhuang L, Wang B, Sauder DN.

J Interferon Cytokine Res. 2000 May;20(5):445-54. Review.

PMID:
10841072
46.

Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case.

Tavadia SM, Mydlarski PR, Reis MD, Mittmann N, Pinkerton PH, Shear N, Sauder DN.

J Am Acad Dermatol. 2000 Apr;42(4):628-32.

PMID:
10727309
47.

Open-label study to evaluate the healing rate and safety of the Profore Extra Four-Layer Bandage System in patients with venous leg ulceration.

Gupta AK, Koven JD, Lester R, Shear NH, Sauder DN.

J Cutan Med Surg. 2000 Jan;4(1):8-11. Erratum in: J Cutan Med Surg 2000 Apr;4(2):62.

PMID:
10689221
49.

Editorial.

Sauder DN.

J Cutan Med Surg. 2000 Jan 1;4(1):1.

PMID:
10689219
50.

Imiquimod, a topical immune response modifier, induces migration of Langerhans cells.

Suzuki H, Wang B, Shivji GM, Toto P, Amerio P, Tomai MA, Miller RL, Sauder DN.

J Invest Dermatol. 2000 Jan;114(1):135-41.

Supplemental Content

Loading ...
Support Center